DOI Assignment for Targeting Mitochondria 2024 Abstracts
We are pleased to announce that all abstracts submitted this year to the 15th Annual meeting of the WMS will be included in the Targeting Mitochondria 2024 Abstracts Book, which will be assigned a DOI (Digital Object Identifier). This ensures your work will have a permanent and easily accessible online presence.
Importance of DOI
Having a DOI means your abstracts will be indexed on major academic platforms such as ORCID, Google Scholar, Scopus and others. This not only enhances the visibility of your research but also facilitates easy citation and sharing within the scientific community.
Abstract Submission Details
You can submit your abstracts here: www.wms-site.com/abstract submission.
Dr. James McCully will be invited by Dr. Marvin Edeas to highlight Mitochondrial Transplantation on March 22
Dr. Marvin Edeas, Institut Cochin, INSERM U1016, Université Paris Cité, France, is pleased to invite Dr. James McCully of Harvard Medical School and Boston Children's Hospital to present a talk dedicated to Mitochondrial Transplantation, both online and in Paris.
The focus of the Dr. McCully's talk will be on "Mitochondrial Transplantation: Rescue of Cellular Viability and Function and Modulation of the Ischemic Phenotype in the Myocardium".
Dr. McCully will discuss the role of mitochondrial transplantation in improving outcomes for myocardial ischemia/reperfusion injury and its effects on the transcriptomic profile.
You are all cordially invited to join us.
World Mitochondria Society
Practical Information
Date & Venue
The webinar is scheduled for Friday, March 22, 2024, from 3:00 PM to 5:15 PM Paris time.
Participants can choose to attend the event in two ways:
- In person at the Université Paris Cité, Institut Cochin - Bâtiment Méchain, Salle Rosalind Franklin, in Paris.
- Virtually, through a Zoom webinar.
Registration & Participation
There is no fee to attend this webinar, but space is limited. Interested individuals are encouraged to register early to ensure participation.
Why did Dr. Marvin Edeas invite Dr. James McCully to host a webinar on Mitochondrial Transplantation?
Dr. McCully plays a strategic role in the field of medicine, especially his groundbreaking work in pediatric cardiac surgery and his development of mitochondrial transplantation. Dr. McCully has dedicated his career to innovating treatment approaches for congenital heart conditions, significantly improving outcomes for pediatric patients. His research has not only advanced surgical procedures but also introduced new technologies to enhance the quality of life for children with heart defects.
The technique of mitochondrial transplantation, pioneered by Dr. McCully, represents a major advancement in medical science, offering a novel method to deliver healthy mitochondria directly to damaged tissues, thus rescuing organ function. This innovation, first applied at Boston Children's Hospital in 2014, has shown that mitochondrial transplantation can safely and effectively restore injured heart muscle, even in critical cases.
Given Dr. McCully's extensive publication record, with 234 papers and 13 patents, and his involvement in leading scientific associations, his expertise and contributions are highly valued by the medical community. His work aligns closely with the interests of the World Mitochondria Society, making him an ideal candidate to share insights on the therapeutic efficacy of mitochondrial transplantation in treating myocardial ischemia/reperfusion injury and its potential for broader applications in medicine.
Evaluation and Quality Control of Mitochondrial Function: Where we are Now & What's Next?
It is a great pleasure to welcome Dr. Egbert Mik, Erasmus MC, The Netherlands, and active member of the WMS scientific committee, at Targeting Mitochondria 2024 this October in Berlin.
Presentation title: Evaluation and Quality Control of Mitochondrial Function: Where we are Now & What's Next?
About Egbert Mik
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
The Power and Potential of Mitochondria Transfer
Dr. Jonathan R. Brestoff, Washington University in St. Louis School of Medicine, USA, will join the 15th WMS Annual Congress on Targeting Mitochondria 2024.
Dr. Brestoff will present his latest research on The Power and Potential of Mitochondria Transfer.
Join Targeting Mitochondria 2024 to learn more about the latest advances in mitochondrial transfer.
About Jonathan R. Brestoff
Jonathan R. Brestoff, M.D., Ph.D., M.P.H., is an assistant professor of pathology and immunology at Washington University School of Medicine (WUSM). He completed his M.D./Ph.D. at the Perelman School of Medicine at the University of Pennsylvania with Dr. David Artis, where Dr. Brestoff’s work identified that group 2 innate lymphoid cells induce beige fat to limit the development of obesity. He then moved to WUSM in 2016 for his residency in pathology, during which time Dr. Brestoff completed his postdoctoral training with Dr. Steven Teitelbaum. For his research on a process called intercellular mitochondria transfer, Dr. Brestoff was awarded the NIH Director’s Early Independence Award and Burroughs Wellcome Fund Career Award for Medical Scientists, allowing him to launch his independent laboratory at WUSM in 2019. His lab continues to study immunometabolism and intercellular mitochondria transfer, leading to his lab’s pioneering studies on mitochondria transfer from adipocytes to macrophages, which was named in Cell Metabolism’s Best of 2021 special issue. His work on these subjects has been published in Nature, Cell, Science, Cell Metabolism, Nature Immunology, Nature Metabolism, and other top journals. He is a member of the scientific advisory board for LUCA Science, Inc., based in Tokyo, and is a trustee at his alma mater, Skidmore College.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
October 28-30, 2024 - Berlin, Germany
LinkedIn | Facebook
Mitochondria Function Evaluation: Workshop Highlights, Methods, Discrepancies, and Recommendations
Dr. Naig Gueguen, CHU Angers, France, will join the 15th WMS Annual Congress on Targeting Mitochondria 2024.
Dr. Gueguen will present the following contribution: "Mitochondria Function Evaluation: Workshop Highlights, Methods, Discrepancies, and Recommendations".
This presentation will summarize the workshop she will host on October 29 about Mitochondrial Evaluation.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
State of the Science Mitochondria-specific Targets, Therapeutics and Biomarkers Investigation following Traumatic Brain Injury in the US Military
It is a great pleasure to welcome Dr. Jignesh D. Pandya, Walter Reed Army Institute of Research, USA, at Targeting Mitochondria 2024 this October in Berlin.
Presentation title: State of the Science Mitochondria-specific Targets, Therapeutics and Biomarkers Investigation following Traumatic Brain Injury in the US Military.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
Mitochondrial Dynamics: Updates and Perspectives
It is a great pleasure to welcome Dr. Ježek Petr, Institute of Physiology of the Czech Academy of Sciences, Czech Republic, at Targeting Mitochondria 2024 this October in Berlin.
Presentation title: Mitochondrial Dynamics: Updates and Perspectives.
Highlights
- Mitochondrial network facilitates rejuvenation of fragments and communication via exosomes.
- Mitochondrial cristae morphology changes with metabolism and oxidative phosphorylation (OXPHOS).
- INS-1EΔe+g cells showed lower ATP synthesis, inhibited insulin secretion (IS), and distinct mitochondrial cristae structures.
- Exosomes from stressed pancreatic cells may communicate stress responses.
- Regular mitochondrial cristae can form without major FO subunits of ATP-synthase.
- Delayed mitophagy in IS-impaired cells might lead to exosomes signaling pathology.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
Role of Light in Regulating Blood Glucose via Mitochondrial Stimulation
It is a great pleasure to welcome Dr. Michael B. Powner, City University of London, United Kingdom, at Targeting Mitochondria 2024 this October in Berlin.
Presentation title: Role of Light in Regulating Blood Glucose via Mitochondrial Stimulation.
About Michael B. Powner
Dr. Michael Powner is a Senior lecturer in Neurobiology, joining the Optometry division at City, University of London in February 2016. Dr. Powner is a neurobiologist who explores the mechanisms behind cellular stress during the early stages of retinal diseases; including age related macular degeneration (AMD) and diabetic retinopathy. He is also passionate about developing or adapting non invasive interventions, including optical and electrical stimulation, to improve patients health and quality of life.
In collaboration with Prof. Jeffery at UCL Institute of Ophthalmology, he is investigating the potential of red light (670nm) as a therapy for aging and ocular diseases, including age related macular degeneration.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
